| _version_ |
1860797978926645248
|
| building |
INTELEK Repository
|
| collection |
Online Access
|
| collectionurl |
https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072
|
| date |
2024-08-30 11:26:00
|
| format |
Restricted Document
|
| id |
15239
|
| institution |
UniSZA
|
| internalnotes |
1. Al-Dubai SA, Alshagga MA, Al-Naggar RA, Al-Jashamy K, Baobaid MF, Tuang CP, Abd Kadir SY, Knowledge, Attitudes and Barriers for Human Papilloma Virus (HPV) Vaccines among Malaysian Women, Asian Pac J Cancer Prev, 11(4), 2010, 887-892. Available from http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4 /c%20887-92%20%20Al-Dubai.pdf (Accessed on 23/03/2014). 2. Zhao FH, Tiggelaar SM, Hu SY, Zhao N, Hong Y, Niyazi M, Gao XH, Ju LR, Zhang LQ, Feng XX, Duan XZ, Song XL, Wang J, Yang Y, Li CQ, Liu JH, Liu JH, Lu YB, Li L, Zhou Q, Liu JF, Xu LN, Qiao YL, A multi-canter survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China, Asian Pac J Cancer Prev, 13(5), 2012, 2369-2378. Available from http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5 /2369-78%202.27%20Fang-Hui%20Zhao.pdf (Accessed on 23/03/2014). 3. Henninger J, Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch, J Prim Health Care, 1(4), 2009, 278- 285. Available from http://jphc.org/jphc/index.php/jphc/article/view/58/44 (Accessed on 23/03/2014). 4. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L, Human papillomavirus and HPV vaccines: a review, Bull World Health Organ, 85(9), 2007, 719-726. Available from www.scielosp.org/pdf/bwho/v85n9/ a18v85n9.pdf (Accessed on 23/03/2014). 5. Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V, Koonsaeng S, Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers, Southeast Asian J Trop Med Public Health, 40(5), 2009, 1048-1056. Available from http://www.tm.mahidol.ac.th/seameo/2009-40- 5/22-4533.pdf (Accessed on 23/03/2014). 6. Malaysia National Cancer Registry Report (MNCRR) 2007. Available from www.makna.org.my/PDF/MalaysiaCancerStatistics2007.pdf (Accessed on 23/03/2014). 7. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX, Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, Lancet Infect Dis, 7(7), 2007, 453-459. Available from http://download.thelancet.com/pdfs/journals/laninf/ PIIS1473309907701585.pdf?id=eaaeAxnlSUt30d8cTeUtu (Accessed on 23/03/2014) 8. Wong LP, Wong YL, Low WY, Khoo EM, Shuib R, Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study, Singapore Med J, 50(1), 2009, 49-53. Available from http://smj.sma.org.sg/5001/5001a6.pdf (Accessed on 23/03/2014). 9. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA, Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases, N Engl J Med, 356(19), 2007, 1928- 1943. Available from www.nejm.org/doi/pdf/10.1056/ NEJMoa061760 (Accessed on 23/03/2014). 10. Mc Carey C, Pirek D, Tebeu PM, Boulvain M, Doh AS, Petignat P, Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers, BMC Women’s Health, 18, 2011, 11-45. Available from www.biomedcentral.com/content/pdf/1472- 6874-11-45.pdf (Accessed on 23/03/2014). 11. Macartney KK, Chiu C, Georgousakis M, Brotherton JM, Safety of human papillomavirus vaccines: a review, Drug Saf, 36(6), 2013, 393-412. Available from http://link.springer.com/article/10.1007/ s40264-013-0039-5#page-1 (Accessed on 23/03/2014). 12. Hawkes D, Lea CE, Berryman MJ, Answering human papillomavirus vaccine concerns; a matter of science and time, Infect Agent Cancer, 8(1), 2013, 22. Doi: 10.1186/1750-9378-8-22 Available from http://www.infectagentscancer.com/content/pdf/1750-9378-8- 22.pdf (Accessed on 23/03/2014). 13. Herzog TJ, Huh WK, Downs LS, Smith JS, Monk BJ, Initial lessons learned in HPV vaccination, Gynecol Oncol, 109 (2 Suppl), 2008, S4- 11. Available from file:///C:/Users/UniSZA/Downloads/66.%20 Thomas%20J.,%20Gynecological%20Oncology,%20109%20(2%20su ppl)%20S4-11.pdf (Accessed on 23/03/2014). 14. Ozsurekci Y, Karadag Oncel E, Bayhan C, Celik M, Ozkaya-Parlakay A, Arvas M, Ceyhan M, Knowledge and attitudes about human papillomaviruses and immunization among Turkish paediatricians, Asian Pac J Cancer Prev, 14(12), 2013, 7325-7329. Available from http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No1 2/7325-7329%208.5%20Yasemin%20Ozsurekci.pdf (Accessed on 23/03/2014). 15. Liddon N, Hood J, Wynn BA, Markowitz LE, Acceptability of human papillomavirus vaccine for males: a review of the literature, J Adolesc Health, 46(2), 2010, 113-123. Available from http://www.sciencedirect.com/science/article/pii/S1054139X09006 089 (Accessed on 23/03/2014). 16. Wong LP, Young multi-ethnic women’s attitudes toward the HPV vaccine and HPV vaccination, Int J Gynaecol Obstet, 103(2), 2008, 131-135. Available from http://umexpert.um.edu.my/file/ publication/00007704_25067.pdf (Accessed on 23/03/2014). 17. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V Kurman R, Shah KV,. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective, J Natl Cancer Inst, 87, 1995, 796-802. Available from http://jnci.oxfordjournals.org/content/87/11/796 (Accessed 7/4/2014). 18. Meyers ER, McCrory DC, Nanda K, Bastian L, Matchar DB, Mathematical modelling for the natural history of human papillomavirus infection and cervical carcinogenesis, Am J Epidemiol, 151, 2000, 1158–1171. Available from http://aje.oxfordjournals.org/content/151/12/1158.full.pdf (Accessed on 6/4/2014). 19. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE, Prevalence of HPV infection among females in the United States, JAMA, 297(8), 2007, 813–819. Available from http://jama.jamanetwork.com/article.aspx?articleid=205774 (Accessed on 6/4/2014). 20. 20. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int J Cancer, 127(12), 2010, 2893-2917. Available from http://onlinelibrary.wiley.com/doi/10.1002/ijc.25516/pdf (Accessed on 7/4/2014). 21. Perkins RB, Langrish SM, Cotton DJ, Simon CJ, Maternal Support for Human Papillomavirus Vaccination in Honduras, J Women Health, 20(1), 2011, 85-90. doi: 10.1080/10705500802365490. Available from www.ncbi.nlm.nih.gov/pmc/articles/PMC3052277/pdf/ jwh.2009.1919.pdf (Accessed on 7/4/2014). 22. Masood S, A plea for a worldwide volunteer cervical cancer education and awareness program, Acta Cytol, 43(4), 1999, 539-542. 23. Ministry of Health Malaysia. Malaysia’s Health Technical Report of the Director-General of Health, Malaysia; 1999. Available from http://www.moh.gov.my/images/gallery/publications/mh/Malaysia %20Health%202008-2.pdf (Accessed on 19/02/2015). 24. 24. Rashwan H, Lubis SH, Ni KA, Knowledge of Cervical Cancer and Acceptance of HPV Vaccination among Secondary School Students in Sarawak, Malaysia, Asian Pacific J Cancer Prev, 12(7), 2011, 1837- 1841. Available from http://www.apocp.org/cancer_download/ Volume12_No7/1837- 1841%20c%206.27%20Hesham%20Rashwan.pdf (Accessed on 7/4/2014). 25. Karim NBSBA, Ismail NMB, Naing MASL, Ismail ARB, Knowledge of Tooth Wear among Secondary School Children in Kota Bharu Kelantan, Int Med J, 18(2), 2011, 156-158. 26. Al-Ansari J, Honkala E, Honkala S, Oral health knowledge and Behaviour among male health sciences college students in Kuwait, BMC Oral Health, 3, 2003, 2. Available from http://www.biomedcentral.com/content/pdf/1472-6831-3-2.pdf (Accessed on 6/4/2014). 27. Wong LP, Wong YL, Low WY, Khoo EM, Shuib R, Cervical cancer screening attitudes and beliefs of Malaysian women who have never had a pap smear: a qualitative study, Int J Behav Med, 15(4), 2008, 289-292. doi: 10.1080/10705500802365490. 28. Salam MM, Uddin MS, Khan MFA, Mazumdar PK, Huq ME, Yousuf R, Salam A, Maternal Awareness on Under-5 Child Immunization in a Rural Community of Bangladesh, Int Med J, 20(6), 2013, 681-684. 29. Chauke-Moagi BE, Mumba M, New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs, Vaccine, 30(Suppl 3), 2012, C3–C8. Available from http://ac.els-cdn.com/S0264410X12008389/1-s2.0- S0264410X12008389-main.pdf (Accessed on 7/4/2014). 30. Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, Wecker J, Duclos P, Greenwood B, The future of immunisation policy, implementation, and financing, The Lancet, 378(9789), 2011, 439– 448. Available from http://ac.els-cdn.com/S0140673611604066/1- s2.0-S0140673611604066-main.pdf (Accessed on 7/4/2014) 31. Perlman S; Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG, Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review, PLOS One, 9(3), 2014, e90912, 1-15. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949716/pdf/pone. 0090912.pdf (Accessed on 7/4/2014) 32. Bosch FX, de Sanjose´ S. 2003. Chapter 1: human papillomavirus and cervical cancer burden and assessment of causality. J Natl Cancer Inst Monogr, 31, 2003, 3–13. Available from http://jncimonographs.oxfordjournals.org/content/2003/31/3.full.p df+html (Accessed on 6/4/2014). 33. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E, Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial, Lancet Oncol, 6, 2005, 271–278. DOI 10.1016/S1470- 2045(05)70101-7. Available from http://ac.elscdn.com/S1470204505701017/1-s2.0-S1470204505701017- main.pdf (Accessed on 6/4/2014). 34. Marlow LAV, Waller J, Wardle J, Public awareness that HPV is a risk factor for cervical cancer, Br J Cancer, 97, 2007, 691-694. Available from www.nature.com/bjc/journal/v97/n5/pdf/6603927a.pdf (Accessed on 6/4/2014). 35. Gerend MA, Magloire ZF, Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults, J Adolesc Health, 42(3), 2008, 237-242. doi: 10.1016/j.jadohealth.2007.08.022. Available from http://ac.elscdn.com/S1054139X07004041/1-s2.0-S1054139X07004041- main.pdf (Accessed 8/4/2014). 36. Friedman AL, Shepeard H, Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice, Health Educ Behav, 34(3), 2007, 471-485. Available from http://heb.sagepub.com.libproxy.dundee.ac.uk/ content/34/3/471.full.pdf+html (Accessed on 8/4/2014). 37. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J, Awareness of human papillomavirus among women attending a well woman clinic, Sex Transm Infect, 79(4), 2003, 320-322. Available from http://sti.bmj.com/content/79/4/320.full.pdf (Accessed on 8/4/2014). 38. Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R, University students’ knowledge and awareness of HPV, Prev Med, 28(6), 1999, 535-541. Available from http://ac.elscdn.com/S0091743599904863/1-s2.0-S0091743599904863- main.pdf (Accessed 8/4/2014). 39. Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L, Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007, Prev Med, 48(5), 2009, 426-431. doi: 10.1016/j.ypmed.2008.11.010. Epub 2008 Dec 6. Available from http://ac.els-cdn.com/S0091743508006269/1-s2.0- S0091743508006269-main.pdf (Accessed on 8/4/2014).
|
| originalfilename |
6032-01-FH02-FP-15-03317.pdf
|
| person |
Adobe Acrobat 20.6
|
| recordtype |
oai_dc
|
| resourceurl |
https://intelek.unisza.edu.my/intelek/pages/view.php?ref=15239
|
| spelling |
15239 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=15239 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Article Journal application/pdf Adobe Acrobat Pro DC 20 Paper Capture Plug-in with ClearScan 6 1.6 Adobe Acrobat 20.6 2024-08-30 11:26:00 6032-01-FH02-FP-15-03317.pdf UniSZA Private Access A Pilot Survey of Awareness and Knowledge of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Men and Women Attending for HPV Vaccination in Terengganu, Malaysia International Journal of Pharmaceutical Sciences Review and Research Cervical cancer is a major public health problem and it is the leading cause of cancer-related deaths in women as reported. The primary underlying cause of cervical cancer is human papilloma virus (HPV) which is the most common sexually transmitted infection. A little is known about the awareness and knowledge of HPV infection, cervical cancer and HPV vaccine in Malaysian women and men. Therefore, this survey is aimed to assess. A cross-sectional survey study was conducted at Universiti Sultan Zainal Abidin, Terengganu, Malaysia using a self-administered, anonymous questionnaire. A total of 112 women and men aged 15-45 years were included who came for HPV vaccination. Data were analysed with SPSS version 16.0 using standard descriptive statistic and P-values < 0.05 were considered significant. Mean age of respondents was 30 years. Overall, 99% of respondents knew that HPV vaccine protects them from cervical cancer, however, 68% were not aware of its effectiveness; 73% knew that HPV vaccine will not replace Pap smear screening; 94% correctly reported that HPV vaccine is also beneficial for males; 85% knew that HPV vaccine is not safe in pregnancy; Only 45% knew that HPV vaccine can be given during breast feeding; 77% respondents were motivated for vaccination through doctors; interestingly, 70% accepted that the cost of HPV vaccine is within acceptable price range. Study assessed knowledge about HPV infection and its vaccine. Results are encouraging. However, aggressive education is necessary to increase awareness and knowledge of HPV infection and its vaccine. 31 2 242-246 1. Al-Dubai SA, Alshagga MA, Al-Naggar RA, Al-Jashamy K, Baobaid MF, Tuang CP, Abd Kadir SY, Knowledge, Attitudes and Barriers for Human Papilloma Virus (HPV) Vaccines among Malaysian Women, Asian Pac J Cancer Prev, 11(4), 2010, 887-892. Available from http://www.apocpcontrol.org/paper_file/issue_abs/Volume11_No4 /c%20887-92%20%20Al-Dubai.pdf (Accessed on 23/03/2014). 2. Zhao FH, Tiggelaar SM, Hu SY, Zhao N, Hong Y, Niyazi M, Gao XH, Ju LR, Zhang LQ, Feng XX, Duan XZ, Song XL, Wang J, Yang Y, Li CQ, Liu JH, Liu JH, Lu YB, Li L, Zhou Q, Liu JF, Xu LN, Qiao YL, A multi-canter survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China, Asian Pac J Cancer Prev, 13(5), 2012, 2369-2378. Available from http://www.apocpcontrol.org/paper_file/issue_abs/Volume13_No5 /2369-78%202.27%20Fang-Hui%20Zhao.pdf (Accessed on 23/03/2014). 3. Henninger J, Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch, J Prim Health Care, 1(4), 2009, 278- 285. Available from http://jphc.org/jphc/index.php/jphc/article/view/58/44 (Accessed on 23/03/2014). 4. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L, Human papillomavirus and HPV vaccines: a review, Bull World Health Organ, 85(9), 2007, 719-726. Available from www.scielosp.org/pdf/bwho/v85n9/ a18v85n9.pdf (Accessed on 23/03/2014). 5. Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V, Koonsaeng S, Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers, Southeast Asian J Trop Med Public Health, 40(5), 2009, 1048-1056. Available from http://www.tm.mahidol.ac.th/seameo/2009-40- 5/22-4533.pdf (Accessed on 23/03/2014). 6. Malaysia National Cancer Registry Report (MNCRR) 2007. Available from www.makna.org.my/PDF/MalaysiaCancerStatistics2007.pdf (Accessed on 23/03/2014). 7. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX, Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, Lancet Infect Dis, 7(7), 2007, 453-459. Available from http://download.thelancet.com/pdfs/journals/laninf/ PIIS1473309907701585.pdf?id=eaaeAxnlSUt30d8cTeUtu (Accessed on 23/03/2014) 8. Wong LP, Wong YL, Low WY, Khoo EM, Shuib R, Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study, Singapore Med J, 50(1), 2009, 49-53. Available from http://smj.sma.org.sg/5001/5001a6.pdf (Accessed on 23/03/2014). 9. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA, Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases, N Engl J Med, 356(19), 2007, 1928- 1943. Available from www.nejm.org/doi/pdf/10.1056/ NEJMoa061760 (Accessed on 23/03/2014). 10. Mc Carey C, Pirek D, Tebeu PM, Boulvain M, Doh AS, Petignat P, Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers, BMC Women’s Health, 18, 2011, 11-45. Available from www.biomedcentral.com/content/pdf/1472- 6874-11-45.pdf (Accessed on 23/03/2014). 11. Macartney KK, Chiu C, Georgousakis M, Brotherton JM, Safety of human papillomavirus vaccines: a review, Drug Saf, 36(6), 2013, 393-412. Available from http://link.springer.com/article/10.1007/ s40264-013-0039-5#page-1 (Accessed on 23/03/2014). 12. Hawkes D, Lea CE, Berryman MJ, Answering human papillomavirus vaccine concerns; a matter of science and time, Infect Agent Cancer, 8(1), 2013, 22. Doi: 10.1186/1750-9378-8-22 Available from http://www.infectagentscancer.com/content/pdf/1750-9378-8- 22.pdf (Accessed on 23/03/2014). 13. Herzog TJ, Huh WK, Downs LS, Smith JS, Monk BJ, Initial lessons learned in HPV vaccination, Gynecol Oncol, 109 (2 Suppl), 2008, S4- 11. Available from file:///C:/Users/UniSZA/Downloads/66.%20 Thomas%20J.,%20Gynecological%20Oncology,%20109%20(2%20su ppl)%20S4-11.pdf (Accessed on 23/03/2014). 14. Ozsurekci Y, Karadag Oncel E, Bayhan C, Celik M, Ozkaya-Parlakay A, Arvas M, Ceyhan M, Knowledge and attitudes about human papillomaviruses and immunization among Turkish paediatricians, Asian Pac J Cancer Prev, 14(12), 2013, 7325-7329. Available from http://www.apocpcontrol.org/paper_file/issue_abs/Volume14_No1 2/7325-7329%208.5%20Yasemin%20Ozsurekci.pdf (Accessed on 23/03/2014). 15. Liddon N, Hood J, Wynn BA, Markowitz LE, Acceptability of human papillomavirus vaccine for males: a review of the literature, J Adolesc Health, 46(2), 2010, 113-123. Available from http://www.sciencedirect.com/science/article/pii/S1054139X09006 089 (Accessed on 23/03/2014). 16. Wong LP, Young multi-ethnic women’s attitudes toward the HPV vaccine and HPV vaccination, Int J Gynaecol Obstet, 103(2), 2008, 131-135. Available from http://umexpert.um.edu.my/file/ publication/00007704_25067.pdf (Accessed on 23/03/2014). 17. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V Kurman R, Shah KV,. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective, J Natl Cancer Inst, 87, 1995, 796-802. Available from http://jnci.oxfordjournals.org/content/87/11/796 (Accessed 7/4/2014). 18. Meyers ER, McCrory DC, Nanda K, Bastian L, Matchar DB, Mathematical modelling for the natural history of human papillomavirus infection and cervical carcinogenesis, Am J Epidemiol, 151, 2000, 1158–1171. Available from http://aje.oxfordjournals.org/content/151/12/1158.full.pdf (Accessed on 6/4/2014). 19. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE, Prevalence of HPV infection among females in the United States, JAMA, 297(8), 2007, 813–819. Available from http://jama.jamanetwork.com/article.aspx?articleid=205774 (Accessed on 6/4/2014). 20. 20. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int J Cancer, 127(12), 2010, 2893-2917. Available from http://onlinelibrary.wiley.com/doi/10.1002/ijc.25516/pdf (Accessed on 7/4/2014). 21. Perkins RB, Langrish SM, Cotton DJ, Simon CJ, Maternal Support for Human Papillomavirus Vaccination in Honduras, J Women Health, 20(1), 2011, 85-90. doi: 10.1080/10705500802365490. Available from www.ncbi.nlm.nih.gov/pmc/articles/PMC3052277/pdf/ jwh.2009.1919.pdf (Accessed on 7/4/2014). 22. Masood S, A plea for a worldwide volunteer cervical cancer education and awareness program, Acta Cytol, 43(4), 1999, 539-542. 23. Ministry of Health Malaysia. Malaysia’s Health Technical Report of the Director-General of Health, Malaysia; 1999. Available from http://www.moh.gov.my/images/gallery/publications/mh/Malaysia %20Health%202008-2.pdf (Accessed on 19/02/2015). 24. 24. Rashwan H, Lubis SH, Ni KA, Knowledge of Cervical Cancer and Acceptance of HPV Vaccination among Secondary School Students in Sarawak, Malaysia, Asian Pacific J Cancer Prev, 12(7), 2011, 1837- 1841. Available from http://www.apocp.org/cancer_download/ Volume12_No7/1837- 1841%20c%206.27%20Hesham%20Rashwan.pdf (Accessed on 7/4/2014). 25. Karim NBSBA, Ismail NMB, Naing MASL, Ismail ARB, Knowledge of Tooth Wear among Secondary School Children in Kota Bharu Kelantan, Int Med J, 18(2), 2011, 156-158. 26. Al-Ansari J, Honkala E, Honkala S, Oral health knowledge and Behaviour among male health sciences college students in Kuwait, BMC Oral Health, 3, 2003, 2. Available from http://www.biomedcentral.com/content/pdf/1472-6831-3-2.pdf (Accessed on 6/4/2014). 27. Wong LP, Wong YL, Low WY, Khoo EM, Shuib R, Cervical cancer screening attitudes and beliefs of Malaysian women who have never had a pap smear: a qualitative study, Int J Behav Med, 15(4), 2008, 289-292. doi: 10.1080/10705500802365490. 28. Salam MM, Uddin MS, Khan MFA, Mazumdar PK, Huq ME, Yousuf R, Salam A, Maternal Awareness on Under-5 Child Immunization in a Rural Community of Bangladesh, Int Med J, 20(6), 2013, 681-684. 29. Chauke-Moagi BE, Mumba M, New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs, Vaccine, 30(Suppl 3), 2012, C3–C8. Available from http://ac.els-cdn.com/S0264410X12008389/1-s2.0- S0264410X12008389-main.pdf (Accessed on 7/4/2014). 30. Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, Wecker J, Duclos P, Greenwood B, The future of immunisation policy, implementation, and financing, The Lancet, 378(9789), 2011, 439– 448. Available from http://ac.els-cdn.com/S0140673611604066/1- s2.0-S0140673611604066-main.pdf (Accessed on 7/4/2014) 31. Perlman S; Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG, Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review, PLOS One, 9(3), 2014, e90912, 1-15. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949716/pdf/pone. 0090912.pdf (Accessed on 7/4/2014) 32. Bosch FX, de Sanjose´ S. 2003. Chapter 1: human papillomavirus and cervical cancer burden and assessment of causality. J Natl Cancer Inst Monogr, 31, 2003, 3–13. Available from http://jncimonographs.oxfordjournals.org/content/2003/31/3.full.p df+html (Accessed on 6/4/2014). 33. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E, Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial, Lancet Oncol, 6, 2005, 271–278. DOI 10.1016/S1470- 2045(05)70101-7. Available from http://ac.elscdn.com/S1470204505701017/1-s2.0-S1470204505701017- main.pdf (Accessed on 6/4/2014). 34. Marlow LAV, Waller J, Wardle J, Public awareness that HPV is a risk factor for cervical cancer, Br J Cancer, 97, 2007, 691-694. Available from www.nature.com/bjc/journal/v97/n5/pdf/6603927a.pdf (Accessed on 6/4/2014). 35. Gerend MA, Magloire ZF, Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults, J Adolesc Health, 42(3), 2008, 237-242. doi: 10.1016/j.jadohealth.2007.08.022. Available from http://ac.elscdn.com/S1054139X07004041/1-s2.0-S1054139X07004041- main.pdf (Accessed 8/4/2014). 36. Friedman AL, Shepeard H, Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice, Health Educ Behav, 34(3), 2007, 471-485. Available from http://heb.sagepub.com.libproxy.dundee.ac.uk/ content/34/3/471.full.pdf+html (Accessed on 8/4/2014). 37. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J, Awareness of human papillomavirus among women attending a well woman clinic, Sex Transm Infect, 79(4), 2003, 320-322. Available from http://sti.bmj.com/content/79/4/320.full.pdf (Accessed on 8/4/2014). 38. Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R, University students’ knowledge and awareness of HPV, Prev Med, 28(6), 1999, 535-541. Available from http://ac.elscdn.com/S0091743599904863/1-s2.0-S0091743599904863- main.pdf (Accessed 8/4/2014). 39. Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L, Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007, Prev Med, 48(5), 2009, 426-431. doi: 10.1016/j.ypmed.2008.11.010. Epub 2008 Dec 6. Available from http://ac.els-cdn.com/S0091743508006269/1-s2.0- S0091743508006269-main.pdf (Accessed on 8/4/2014).
|
| spellingShingle |
A Pilot Survey of Awareness and Knowledge of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Men and Women Attending for HPV Vaccination in Terengganu, Malaysia
|
| summary |
Cervical cancer is a major public health problem and it is the leading cause of cancer-related deaths in women as reported. The primary underlying cause of cervical cancer is human papilloma virus (HPV) which is the most common sexually transmitted infection. A little is known about the awareness and knowledge of HPV infection, cervical cancer and HPV vaccine in Malaysian women and men. Therefore, this survey is aimed to assess. A cross-sectional survey study was conducted at Universiti Sultan Zainal Abidin, Terengganu, Malaysia using a self-administered, anonymous questionnaire. A total of 112 women and men aged 15-45 years were included who came for HPV vaccination. Data were analysed with SPSS version 16.0 using standard descriptive statistic and P-values < 0.05 were considered significant. Mean age of respondents was 30 years. Overall, 99% of respondents knew that HPV vaccine protects them from cervical cancer, however, 68% were not aware of its effectiveness; 73% knew that HPV vaccine will not replace Pap smear screening; 94% correctly reported that HPV vaccine is also beneficial for males; 85% knew that HPV vaccine is not safe in pregnancy; Only 45% knew that HPV vaccine can be given during breast feeding; 77% respondents were motivated for vaccination through doctors; interestingly, 70% accepted that the cost of HPV vaccine is within acceptable price range. Study assessed knowledge about HPV infection and its vaccine. Results are encouraging. However, aggressive education is necessary to increase awareness and knowledge of HPV infection and its vaccine.
|
| title |
A Pilot Survey of Awareness and Knowledge of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Men and Women Attending for HPV Vaccination in Terengganu, Malaysia
|
| title_full |
A Pilot Survey of Awareness and Knowledge of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Men and Women Attending for HPV Vaccination in Terengganu, Malaysia
|
| title_fullStr |
A Pilot Survey of Awareness and Knowledge of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Men and Women Attending for HPV Vaccination in Terengganu, Malaysia
|
| title_full_unstemmed |
A Pilot Survey of Awareness and Knowledge of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Men and Women Attending for HPV Vaccination in Terengganu, Malaysia
|
| title_short |
A Pilot Survey of Awareness and Knowledge of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Men and Women Attending for HPV Vaccination in Terengganu, Malaysia
|
| title_sort |
pilot survey of awareness and knowledge of human papillomavirus (hpv), cervical cancer and hpv vaccine among men and women attending for hpv vaccination in terengganu, malaysia
|